2024-08-31 22:12:03
A child infected with MPOX in a health center in Muniji, near Goma, North Kivu province, Democratic Republic of the Congo, on August 19, 2024.
UNICEF announced the launch on Saturday, August 31 “Emergency Tendering” To get a vaccine against multiple acne so that we can help the worst-affected countries. “Depending on demand, manufacturer’s production capacity and financing, agreements covering up to 12 million doses of vaccine in 2025 could be entered into”UNICEF announced in a statement communiquépublished jointly with the World Health Organization, the Gavi Vaccine Alliance and the Africa CDC (Africa Centers for Disease Control and Prevention). this “Emergency tender aimed at ensuring immediate access to existing mpox vaccines and increasing production”specify the press release.
As part of the tender, UNICEF hopes to develop supply agreements that will enable it to acquire and distribute vaccines “This will be in place as soon as countries and partners secure funding, confirm demand and readiness levels and regulatory requirements for vaccine acceptance are in place”.
The resurgence of MPOX in Africa, affecting the Democratic Republic of the Congo (DRC) and other countries on the continent (notably Burundi, Kenya, Rwanda and Uganda), as well as the emergence of new variants (1b), prompted the World Health Organization to trigger the August 14 On the same day, the global health alert level was the highest.
READ ALSO | Article reserved for Mpox subscribers in Democratic Republic of Congo: Responses have been reorganized
Add to your selection
More than 200 people have died in Democratic Republic of Congo
The Democratic Republic of the Congo has reported more than 18,000 suspected cases of MPOX this year, including 629 deaths. ‘This is the center of the crisis’according to the press release, which specifies ‘Four out of five deaths involve children’. There are two large families called «Clade»viral. Clade 1 is mainly found in the Congo Basin in central Africa. Clade 2 is prevalent mainly in West Africa. The Democratic Republic of Congo has two MPOX subpopulations: clade 1a (in the west of the country) and clade 1b (in the east).
The World Health Organization recommends using the MVA-BN vaccine produced by the Nordic Pharmaceutical Laboratory in Bavaria, Denmark, or the LC16 vaccine produced by Japan’s KM Biologics, or the ACAM2000 vaccine produced in the United States, in the absence of the first two vaccines. MVA-BN and LC16 are not yet available “Pre-qualification” The WHO’s comprehensive review process is long and complex, and the organization has launched an emergency review.
“WHO is currently reviewing the information submitted by the manufacturer on August 23 and is expected to complete the emergency use list review in mid-September.”indicating a press release.
READ ALSO | Article reserved for our Mpox subscribers: Genetic characteristics of the viruses involved in the “fight against humanity”
Add to your selection
Reuse this content
1725153253
#Faced #mpox #UNICEF #launches #tender #obtain #vaccines
